Related Experiment Video
Updated: Jun 15, 2025

Glomerular Outgrowth as an Ex Vivo Assay to Analyze Pathways Involved in Parietal Epithelial Cell Activation
Published on: August 19, 2020
Podocyte FFAR4 deficiency aggravated glomerular diseases and aging
Ting Yin1, Letian Yang2, Lei Tang2
1Department of Nephrology, Institute of Kidney Diseases, West China Hospital of Sichuan University, Chengdu 610041, China; Department of Pathology, Institute of Clinical Pathology, West China Hospital of Sichuan University, Chengdu 610041, China.
Free fatty acid receptor 4 (FFAR4) protects podocytes from injury and aging by activating CaMKKβ-AMPK signaling. Restoring FFAR4 function offers a promising therapeutic strategy for kidney diseases.
Area of Science:
- Nephrology
- Molecular Biology
- Gerontology
Background:
- Podocyte injury drives glomerular disease progression and aging.
- Current therapies for kidney outcomes are limited, with poorly defined causative pathways.
- Free fatty acid receptor 4 (FFAR4) agonists previously showed promise in diabetic nephropathy.
Purpose of the Study:
- To investigate the role of podocyte FFAR4 in glomerular diseases and aging.
- To explore FFAR4 as a potential therapeutic target for kidney protection.
Main Methods:
- Assessed glomerular FFAR4 expression in human patients and mouse models (focal segmental glomerulosclerosis, diabetic kidney disease).
- Utilized systemic and podocyte-specific FFAR4 deletion models.
- Administered FFAR4 agonist TUG891 and fish oil in adriamycin-induced nephropathy, diabetic, and aging mouse models.
- Investigated FFAR4's mechanistic effects on cellular senescence and lipid metabolism via CaMKKβ-AMPK signaling.
Main Results:
- Glomerular FFAR4 expression was decreased in patients with glomerular diseases and correlated with kidney function decline.
- FFAR4 deficiency exacerbated glomerular damage in mouse models.
- FFAR4 agonism (TUG891, fish oil) alleviated kidney injury in various disease models.
- FFAR4 reduction induced podocyte senescence and lipid metabolism disorder.
- FFAR4 activation via CaMKKβ-AMPK signaling demonstrated anti-senescent and anti-lipotoxic effects.
Conclusions:
- FFAR4 plays a critical protective role in podocytes against injury and aging.
- FFAR4 dysfunction contributes to cellular senescence and lipid metabolism abnormalities in kidney disease.
- Targeting FFAR4 offers a novel therapeutic avenue for glomerular diseases and age-related kidney decline.
Related Concept Videos
Renal Corpuscle
Glomerulus: Structure and Function
The glomerulus is a tiny, intricate network of capillaries located at the beginning of the nephron. It's enveloped by the Bowman's capsule and receives its blood supply from an afferent arteriole, which divides into numerous...
Nephrons
Glomerular Filtration
Components of the Filtration Membrane
The filtration process involves three key layers: the glomerular endothelial cells, the basement membrane, and the podocyte-formed filtration slits.
Factors Affecting Renal Clearance: Renal Impairment
One condition associated with renal failure is uremia. Uremia is characterized by impaired glomerular filtration and fluid accumulation in the body. This condition hinders the renal clearance of drugs, resulting in drug accumulation and potential...
Glomerular Filtration Rate and its Regulation
GFR regulation involves two primary intrinsic controls: the myogenic and tubuloglomerular feedback mechanisms.
The myogenic...

